127 related articles for article (PubMed ID: 37013349)
21. Primary intramucosal synovial sarcoma of the sigmoid colon in a patient with a germline mutation in the MSH2 gene: A case report.
Shigematsu Y; Yamashita K; Takamatsu M; Tanizawa T; Togashi Y; Nakajima T; Chino A; Kawachi H; Takeuchi K
Pathol Int; 2020 Dec; 70(12):1015-1019. PubMed ID: 32940945
[TBL] [Abstract][Full Text] [Related]
22. Lynch syndrome and Muir-Torre phenotype associated with a recurrent variant in the 3'UTR of the MSH6 gene.
Cini G; Carnevali I; Sahnane N; Chiaravalli AM; Dell'Elice A; Maestro R; Pin E; Bestetti I; Radovic S; Armelao F; Viel A; Tibiletti MG
Cancer Genet; 2021 Jun; 254-255():1-10. PubMed ID: 33516942
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair.
Wielders EA; Hettinger J; Dekker R; Kets CM; Ligtenberg MJ; Mensenkamp AR; van den Ouweland AM; Prins J; Wagner A; Dinjens WN; Dubbink HJ; van Hest LP; Menko F; Hogervorst F; Verhoef S; te Riele H
J Med Genet; 2014 Apr; 51(4):245-53. PubMed ID: 24501230
[TBL] [Abstract][Full Text] [Related]
24. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
[TBL] [Abstract][Full Text] [Related]
25. A cryptic paracentric inversion of MSH2 exons 2-6 causes Lynch syndrome.
Liu Q; Hesson LB; Nunez AC; Packham D; Williams R; Ward RL; Sloane MA
Carcinogenesis; 2016 Jan; 37(1):10-17. PubMed ID: 26498247
[TBL] [Abstract][Full Text] [Related]
26. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
[TBL] [Abstract][Full Text] [Related]
27. Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomes.
Bogani G; Tibiletti MG; Ricci MT; Carnevali I; Liberale V; Paolini B; Milione M; Vitellaro M; Murgia F; Chiappa V; Ditto A; Ghezzi F; Raspagliesi F
Int J Gynecol Cancer; 2020 Jan; 30(1):56-61. PubMed ID: 31780564
[TBL] [Abstract][Full Text] [Related]
28. Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors.
Rahner N; Brockschmidt FF; Steinke V; Kahl P; Becker T; Vasen HF; Wijnen JT; Tops CJ; Holinski-Feder E; Ligtenberg MJ; Spruijt L; Görgens H; Stemmler S; Kloor M; Dietmaier W; ; Schumacher J; Nöthen MM; Propping P
Fam Cancer; 2012 Mar; 11(1):19-26. PubMed ID: 22086303
[TBL] [Abstract][Full Text] [Related]
29. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.
Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M
Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989
[TBL] [Abstract][Full Text] [Related]
30. Anaplastic oligodendroglioma in an adolescent with Lynch syndrome.
Heath JA; Ng J; Beshay V; Coleman L; Lo P; Amor DJ
Pediatr Blood Cancer; 2013 Jun; 60(6):E13-5. PubMed ID: 23255519
[TBL] [Abstract][Full Text] [Related]
31. Characterization of novel, large duplications in the MSH2 gene of three unrelated Lynch syndrome patients.
Liccardo R; De Rosa M; Rossi GB; Rigler G; Izzo P; Duraturo F
Cancer Genet; 2018 Feb; 221():19-24. PubMed ID: 29405992
[TBL] [Abstract][Full Text] [Related]
32. Pathogenicity of A600V variant in exon 12 of the MSH2 gene detected in a Japanese kindred with Lynch syndrome.
Miyakura Y; Sugano K; Nomizu T; Lefor A; Yasuda Y
Jpn J Clin Oncol; 2012 Jan; 42(1):78-82. PubMed ID: 22086974
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification.
Musulen E; Blanco I; Carrato C; Fernandez-Figueras MT; Pineda M; Capella G; Ariza A
Hum Pathol; 2013 Mar; 44(3):412-6. PubMed ID: 23026194
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
[TBL] [Abstract][Full Text] [Related]
35. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
[TBL] [Abstract][Full Text] [Related]
36. RNA Analysis Identifies Pathogenic Duplications in MSH2 in Patients With Lynch Syndrome.
Conner BR; Hernandez F; Souders B; Landrith T; Boland CR; Karam R
Gastroenterology; 2019 May; 156(6):1924-1925.e4. PubMed ID: 30710526
[No Abstract] [Full Text] [Related]
37. Impact of gene-specific germline pathogenic variants on presentation of endometrial cancer in Lynch syndrome.
Bogani G; Ricci MT; Vitellaro M; Ditto A; Chiappa V; Raspagliesi F
Int J Gynecol Cancer; 2019 May; 29(4):705-710. PubMed ID: 30772826
[TBL] [Abstract][Full Text] [Related]
38. Ectopic, retroperitoneal adrenocortical carcinoma in the setting of Lynch syndrome.
Wright JP; Montgomery KW; Tierney J; Gilbert J; Solórzano CC; Idrees K
Fam Cancer; 2018 Jul; 17(3):381-385. PubMed ID: 28940135
[TBL] [Abstract][Full Text] [Related]
39. Two-stain immunohistochemical screening for Lynch syndrome in colorectal cancer may fail to detect mismatch repair deficiency.
Pearlman R; Markow M; Knight D; Chen W; Arnold CA; Pritchard CC; Hampel H; Frankel WL
Mod Pathol; 2018 Dec; 31(12):1891-1900. PubMed ID: 29967423
[TBL] [Abstract][Full Text] [Related]
40. Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer.
Takeda T; Tsuji K; Banno K; Yanokura M; Kobayashi Y; Tominaga E; Aoki D
J Gynecol Oncol; 2018 May; 29(3):e29. PubMed ID: 29400022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]